New drug aims to quiet artery inflammation in heart disease patients
NCT ID NCT06263244
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 36 times
Summary
This study tests whether ziltivekimab, an anti-inflammatory drug, can reduce swelling in the heart's arteries. About 40 adults with heart disease and high inflammation will receive either the drug or a placebo. Researchers will use special scans and blood tests to see if the drug lowers artery inflammation and changes immune cell activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC, location AMC
RECRUITINGAmsterdam, 1105AZ, Netherlands
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.